Comprehensive Transcriptomic and Proteomic Analyses Identify a Candidate Gene Set in Cross-Resistance for Endocrine Therapy in Breast Cancer

Endocrine therapy (ET) of selective estrogen receptor modulators (SERMs), selective estrogen receptor downregulators (SERDs), and aromatase inhibitors (AIs) has been used as the gold standard treatment for hormone-receptor-positive (HR+) breast cancer. Despite its clinical benefits, approximately 30...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chung-Liang, Moi, Sin-Hua, Lin, Huei-Shan, Hou, Ming-Feng, Chen, Fang-Ming, Shih, Shen-Liang, Kan, Jung-Yu, Kao, Chieh-Ni, Wu, Yi-Chia, Kao, Li-Chun, Chen, Ying-Hsuan, Lee, Yi-Chen, Chiang, Chih-Po
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501051/
https://www.ncbi.nlm.nih.gov/pubmed/36142451
http://dx.doi.org/10.3390/ijms231810539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501051/
https://www.ncbi.nlm.nih.gov/pubmed/36142451
http://dx.doi.org/10.3390/ijms231810539

Ejemplares similares